Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management

Irish Critical Care Trials Group, M Sheridan, M Donnelly, R Bailie, M Power, P Seigne, S Austin, B Marsh, C Motherway, M Scully, C Fagan, P Benson, D McAuley, J Trinder, J Bates, K Bailie, Irish Critical Care Trials Group, M Sheridan, M Donnelly, R Bailie, M Power, P Seigne, S Austin, B Marsh, C Motherway, M Scully, C Fagan, P Benson, D McAuley, J Trinder, J Bates, K Bailie

Abstract

Introduction: The aim of this study was to describe the epidemiology and management of acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) in Ireland.

Methods: As part of a 10-week prospective national audit of patient demographics and organ failure incidence in intensive care in Ireland, all patients with ALI/ARDS in 14 participating centres were prospectively identified using American European Consensus Conference definitions.

Results: There were 1,029 admissions during the study period; of these, 728 patients were invasively ventilated. A total of 196 (19%) patients had ALI/ARDS, and 141 of these (72%) had ALI/ARDS on admission and a further 55 (28%) developed ALI/ARDS after admission. For the patients with ALI/ARDS, the mean (+/- standard deviation) age was 58 +/- 17 years and 62% were male. The most common predisposing risk factors were pneumonia (50%) and nonpulmonary sepsis (26%). Mean (+/- standard deviation) tidal volume/kg was 7.0 +/- 1.7 ml/kg. Median (interquartile range) duration of ventilation was 6.8 (2.0 to 12.8) days. Median (interquartile range) length of stay in the intensive care unit was 10.0 (5.0 to 18.5) days. The overall intensive care unit mortality for ALI/ARDS was 32.3%. Lower baseline arterial oxygen tension/fraction of inspired oxygen ratio and higher Sequential Organ Failure Assessment scores were associated with increased mortality. Although not significant, patients receiving treatment with a statin during admission had a 73% lower odds of death (odds ratio 0.27, 95% confidence interval 0.06 to 1.21; P = 0.09).

Conclusion: The incidence of ALI/ARDS is high and is associated with significant mortality. Protective lung ventilation is used commonly throughout participating centres. With low tidal volume ventilation, the degree of hypoxaemia is associated with outcome. These data will inform future multicentre clinical trials in ALI/ARDS in Ireland.

Figures

Figure 1
Figure 1
Patients with ALI/ARDS stratified by age and relative to all admissions. (a) Proportion of patients with acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) in each age group and (b) proportion of patients with ALI/ARDS relative to all admissions in each age group.
Figure 2
Figure 2
Clinical risk factors for ALI/ARDS and associated risk for mortality. ALI, acute lung injury; ARDS, acute respiratory distress syndrome.
Figure 3
Figure 3
Mean tidal volume. Mean tidal volume (normalized to actual body weight) recorded on the day of diagnosis of acute lung injury/acute respiratory distress syndrome: (a) frequency distribution and (b) associated mortality.
Figure 4
Figure 4
Mortality associated with PaO2/FiO2 ratio quartiles on the day of diagnosis of ALI/ARDS. ALI, acute lung injury; ARDS, acute respiratory distress syndrome; FiO2, fraction of inspired oxygen; PaO2, arterial oxygen tension.
Figure 5
Figure 5
Mortality associated with organ dysfunction on day of diagnosis of ALI/ARDS. Organ dysfunction was assessed based on Sequential Organ Failure Assessment score quartiles. ALI, acute lung injury; ARDS, acute respiratory distress syndrome.
Figure 6
Figure 6
Mortality in patients with ALI/ARDS receiving treatment with a statin during admission. ALI, acute lung injury; ARDS, acute respiratory distress syndrome.

References

    1. Unit Costs of Health and Social Care
    1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–1349. doi: 10.1056/NEJM200005043421806.
    1. Craig T, O'Kane CM, McAuley DF. Potential mechanisms by which statins modulate pathogenic mechanisms important in the development of acute lung injury. In: Vincent JL, editor. 27th Yearbook of Intensive Care and Emergency Medicine. Berlin, Germany: Springer-Verlag; 2007. pp. 287–300.
    1. Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga C, Mulligan MS. Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg. 2003;126:482–489. doi: 10.1016/S0022-5223(03)00699-8.
    1. Fischetti F, Carretta R, Borotto G, Durigutto P, Bulla R, Meroni PL, Tedesco F. Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. Clin Exp Immunol. 2004;135:186–193. doi: 10.1111/j.1365-2249.2003.02358.x.
    1. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;288:L1026–L1032. doi: 10.1152/ajplung.00354.2004.
    1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–824.
    1. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–710. doi: 10.1007/BF01709751.
    1. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A, Damas P, Armaganidis A, Lemaire F, ALIVE Study Group Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 2004;30:51–61. doi: 10.1007/s00134-003-2022-6.
    1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685–1693. doi: 10.1056/NEJMoa050333.
    1. Hughes M, MacKirdy N, Ross J, Norrie J, Grant IS on behalf of the Scottish Intensive Care Society Acute respiratory distress syndrome: an audit of incidence and outcome in Scottish intensive care units. Anaesthesia. 2003;58:838–845. doi: 10.1046/j.1365-2044.2003.03287.x.
    1. The ARDS Network investigators Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308. doi: 10.1056/NEJM200005043421801.
    1. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–2575. doi: 10.1056/NEJMoa062200.
    1. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351:327–336. doi: 10.1056/NEJMoa032193.
    1. Weinert CR, Gross CR, Marinelli WA. Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals. Am J Respir Crit Care Med. 2003;167:1304–1309. doi: 10.1164/rccm.200205-478OC.
    1. Young MP, Manning HL, Wilson DL, Mette SA, Riker RR, Leiter JCM, Liu SK, Bates JT, Parsons PE. Ventilation of patients with acute lung injury and acute respiratory distress syndrome: has new evidence changed clinical practice? Crit Care Med. 2004;32:1260–1265. doi: 10.1097/01.CCM.0000127784.54727.56.
    1. Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, Dhainaut JF, Brunet F. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med. 1998;158:1076–1081.
    1. Sakr Y, Vincent J-L, Reinhart K, Groeneveld J, Michalopoulos A, Sprung CL, Artigas A, Ranieri VM, on behalf of the Sepsis Occurrence in Acutely Ill Patients Investigators High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest. 2005;128:3098–3108. doi: 10.1378/chest.128.5.3098.
    1. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med. 1995;152:1818–1824.
    1. Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med. 1998;157:1159–1164.
    1. Nuckton TJ, Alonso JA, Kallet RH, Daniel BM, Pittet JF, Eisner MD, Matthay MA. Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med. 2002;346:1281–1286. doi: 10.1056/NEJMoa012835.
    1. Ferguson ND, Kacmarek RM, Chiche JD, Singh JM, Hallett DC, Mehta S, Stewart TE. Screening of ARDS patients using standardized ventilatory settings: influence on enrolment in a clinical trial. Intensive Care Med. 2004;30:1111–1116. doi: 10.1007/s00134-004-2163-2.
    1. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Häfner D, Taut FJ, Seeger W. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med. 2004;351:884–892. doi: 10.1056/NEJMoa033181.
    1. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY, Carvalho CR. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998;338:347–354. doi: 10.1056/NEJM199802053380602.
    1. Hager DN, Krishnan JA, Hayden D, Brower R. Tidal volume reduction in patients with acute lung inury when plateau pressures are not hig. Am J Respir Crit Care Med. 2005;172:1241–1245. doi: 10.1164/rccm.200501-048CP.
    1. Ferguson ND, Frutos-Vivar F, Esteban A, Anzueto A, Alía I, Brower RG, Stewart TE, Apezteguía C, González M, Soto L, Abroug F, Brochard L, Mechanical Ventilation International Study Group Airway pressures, tidal volumes, and mortality in patients with acute respiratory distress syndrome. Crit Care Med. 2005;33:21–30. doi: 10.1097/01.CCM.0000150652.91411.66.
    1. Eisner MD, Thompson T, Hudson LD, Luce JM, Hayden D, Schoenfeld D, Matthay MA. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;164:231–236.
    1. Luhr OR, Karlsson M, Thorsteinsson A, Rylander C, Frostell CG. The impact of respiratory variables on mortality in non-ARDS and ARDS patients requiring mechanical ventilation. Intensive Care Med. 2000;26:508–517. doi: 10.1007/s001340051197.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel